193 related articles for article (PubMed ID: 17638915)
1. Control of Her-2 tumor immunity and thyroid autoimmunity by MHC and regulatory T cells.
Jacob JB; Kong YC; Meroueh C; Snower DP; David CS; Ho YS; Wei WZ
Cancer Res; 2007 Jul; 67(14):7020-7. PubMed ID: 17638915
[TBL] [Abstract][Full Text] [Related]
2. Activity of DNA vaccines encoding self or heterologous Her-2/neu in Her-2 or neu transgenic mice.
Jacob J; Radkevich O; Forni G; Zielinski J; Shim D; Jones RF; Wei WZ
Cell Immunol; 2006 Apr; 240(2):96-106. PubMed ID: 16930573
[TBL] [Abstract][Full Text] [Related]
3. Differential requirement for autoantibody-producing B cells for induction of lymphocytic versus granulomatous experimental autoimmune thyroiditis.
Braley-Mullen H; Sharp GC; Kyriakos M
J Immunol; 1994 Jan; 152(1):307-14. PubMed ID: 8254200
[TBL] [Abstract][Full Text] [Related]
4. Concurrent induction of antitumor immunity and autoimmune thyroiditis in CD4+ CD25+ regulatory T cell-depleted mice.
Wei WZ; Jacob JB; Zielinski JF; Flynn JC; Shim KD; Alsharabi G; Giraldo AA; Kong YC
Cancer Res; 2005 Sep; 65(18):8471-8. PubMed ID: 16166327
[TBL] [Abstract][Full Text] [Related]
5. CD4+CD25+ naturally occurring regulatory T cells and not lymphopenia play a role in the pathogenesis of iodide-induced autoimmune thyroiditis in NOD-H2h4 mice.
Nagayama Y; Horie I; Saitoh O; Nakahara M; Abiru N
J Autoimmun; 2007; 29(2-3):195-202. PubMed ID: 17826032
[TBL] [Abstract][Full Text] [Related]
6. Interference with CD4+CD25+ T-cell-mediated tolerance to experimental autoimmune thyroiditis by glucocorticoid-induced tumor necrosis factor receptor monoclonal antibody.
Morris GP; Kong YC
J Autoimmun; 2006 Feb; 26(1):24-31. PubMed ID: 16253477
[TBL] [Abstract][Full Text] [Related]
7. Her-2 DNA versus cell vaccine: immunogenicity and anti-tumor activity.
Whittington PJ; Radkevich-Brown O; Jacob JB; Jones RF; Weise AM; Wei WZ
Cancer Immunol Immunother; 2009 May; 58(5):759-67. PubMed ID: 18836716
[TBL] [Abstract][Full Text] [Related]
8. Flexibility of TCR repertoire and permissiveness of HLA-DR3 molecules in experimental autoimmune thyroiditis in nonobese diabetic mice.
Flynn JC; Fuller BE; Giraldo AA; Panos JC; David CS; Kong YC
J Autoimmun; 2001 Aug; 17(1):7-15. PubMed ID: 11488633
[TBL] [Abstract][Full Text] [Related]
9. Application of HLA class II transgenic mice to study autoimmune regulation.
Kong YC; Flynn JC; Banga JP; David CS
Thyroid; 2007 Oct; 17(10):995-1003. PubMed ID: 17900224
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer.
Yamamoto M; Kamigaki T; Yamashita K; Hori Y; Hasegawa H; Kuroda D; Moriyama H; Nagata M; Ku Y; Kuroda Y
Oncol Rep; 2009 Aug; 22(2):337-43. PubMed ID: 19578774
[TBL] [Abstract][Full Text] [Related]
11. Distinctive modulation by IL-4 and IL-10 of the effector function of murine thyroglobulin-primed cells in "transfer-experimental autoimmune thyroiditis".
Mignon-Godefroy K; Brazillet MP; Rott O; Charreire J
Cell Immunol; 1995 May; 162(2):171-7. PubMed ID: 7743543
[TBL] [Abstract][Full Text] [Related]
12. Experimental autoimmune thyroiditis in nonobese diabetic mice lacking interferon regulatory factor-1.
Jin Z; Mori K; Fujimori K; Hoshikawa S; Tani J; Satoh J; Ito S; Satomi S; Yoshida K
Clin Immunol; 2004 Nov; 113(2):187-92. PubMed ID: 15451476
[TBL] [Abstract][Full Text] [Related]
13. Circumvention of the induction of resistance in murine experimental autoimmune thyroiditis by recombinant IL-1 beta.
Nabozny GH; Kong YC
J Immunol; 1992 Aug; 149(3):1086-92. PubMed ID: 1634763
[TBL] [Abstract][Full Text] [Related]
14. A thyroxine-containing thyroglobulin peptide induces both lymphocytic and granulomatous forms of experimental autoimmune thyroiditis.
Braley-Mullen H; Sharp GC
J Autoimmun; 1997 Dec; 10(6):531-40. PubMed ID: 9451592
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the induction and resolution of granulomatous experimental autoimmune thyroiditis in mice by CD8+ T cells.
Braley-Mullen H; McMurray RW; Sharp GC; Kyriakos M
Cell Immunol; 1994 Feb; 153(2):492-504. PubMed ID: 8118878
[TBL] [Abstract][Full Text] [Related]
16. Enhanced autoimmunity associated with induction of tumor immunity in thyroiditis-susceptible mice.
Kari S; Flynn JC; Zulfiqar M; Snower DP; Elliott BE; Kong YC
Thyroid; 2013 Dec; 23(12):1590-9. PubMed ID: 23777580
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune thyroiditis as an indicator of autoimmune sequelae during cancer immunotherapy.
Kong YC; Jacob JB; Flynn JC; Elliott BE; Wei WZ
Autoimmun Rev; 2009 Sep; 9(1):28-33. PubMed ID: 19254781
[TBL] [Abstract][Full Text] [Related]
18. Tumor regression following DNA vaccination and regulatory T cell depletion in neu transgenic mice leads to an increased risk for autoimmunity.
Jacob JB; Kong YC; Nalbantoglu I; Snower DP; Wei WZ
J Immunol; 2009 May; 182(9):5873-81. PubMed ID: 19380836
[TBL] [Abstract][Full Text] [Related]
19. Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.
Quinn KM; Rich FJ; Goldsack LM; de Lisle GW; Buddle BM; Delahunt B; Kirman JR
Eur J Immunol; 2008 Mar; 38(3):695-705. PubMed ID: 18266274
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
